Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    December 2018
  1. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    PubMed     Text format    


  2. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    PubMed     Text format    


  3. THE LANCET
    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    PubMed     Text format    


    November 2018

  4. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2018;392:1859-1922.
    PubMed     Text format     Abstract available


  5. GRANICH R
    Is the global tuberculosis control strategy too big to fail?
    Lancet. 2018 Nov 1. pii: S0140-6736(18)32751.
    PubMed     Text format    


    October 2018
  6. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Text format     Abstract available


  7. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed     Text format    


  8. MARKS F, Kim JH, Rakotozandrindrainy R
    Madagascar should introduce typhoid conjugate vaccines now.
    Lancet. 2018;392:1309-1310.
    PubMed     Text format    


  9. THE LANCET
    Congenital syphilis in the USA.
    Lancet. 2018;392:1168.
    PubMed     Text format    


  10. COUSINS S
    UN High-Level meeting to end tuberculosis disappointing.
    Lancet. 2018 Oct 3. pii: S0140-6736(18)32458.
    PubMed     Text format    


    September 2018
  11. MARAIS B, Zumla A
    Advancing global tuberculosis control after the UNGA-HLM.
    Lancet. 2018 Sep 24. pii: S0140-6736(18)32361.
    PubMed     Text format    


  12. THE LANCET
    Monkeypox contacts: a puzzling problem.
    Lancet. 2018;392:986.
    PubMed     Text format    


  13. TRIPATHI M, Mohindra S
    Rhinocerebral aspergillosis.
    Lancet. 2018;392:e8.
    PubMed     Text format    


  14. AHMAD N, Ahuja SD, Akkerman OW, Alffenaar JC, et al
    Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet. 2018;392:821-834.
    PubMed     Text format     Abstract available


  15. FARMER PE
    Better and safer treatment for multidrug-resistant tuberculosis.
    Lancet. 2018;392:798-800.
    PubMed     Text format    


  16. REUTER A, Furin J
    Reducing harm in the treatment of multidrug-resistant tuberculosis.
    Lancet. 2018;392:797-798.
    PubMed     Text format    


    August 2018
  17. COUSINS S
    Experts fear a resurgence of leprosy in India.
    Lancet. 2018;392:624-625.
    PubMed     Text format    


  18. THWAITES GE, Szubert A, Walker AS
    Rifampicin in treating S aureus bacteraemia - Authors' reply.
    Lancet. 2018;392:555-556.
    PubMed     Text format    


  19. RIEG S, Kern WV, Soriano A
    Rifampicin in treating S aureus bacteraemia.
    Lancet. 2018;392:554-555.
    PubMed     Text format    


  20. THE LANCET
    Zika-associated health and development problems in children.
    Lancet. 2018;392:532.
    PubMed     Text format    


  21. MBOI N, Murty Surbakti I, Trihandini I, Elyazar I, et al
    On the road to universal health care in Indonesia, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2018;392:581-591.
    PubMed     Text format     Abstract available


  22. BURZA S, Croft SL, Boelaert M
    Leishmaniasis.
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Text format     Abstract available


  23. GARBARINO MC, Cani V, Mazzarello P
    A century ago: Carlo Forlanini and the first successful treatment of tuberculosis.
    Lancet. 2018;392:475.
    PubMed     Text format    


  24. THE LANCET
    Introducing EU-wide surveillance of Lyme neuroborreliosis.
    Lancet. 2018;392:452.
    PubMed     Text format    


    July 2018
  25. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    PubMed     Text format     Abstract available


  26. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available


  27. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    


  28. SEALE AC, Agarwal R
    Improving management of neonatal infections.
    Lancet. 2018;392:100-102.
    PubMed     Text format    


  29. KARTHIKEYAN G, Guilherme L
    Acute rheumatic fever.
    Lancet. 2018;392:161-174.
    PubMed     Text format     Abstract available


  30. SAHA SK, Schrag SJ, El Arifeen S, Mullany LC, et al
    Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study.
    Lancet. 2018;392:145-159.
    PubMed     Text format     Abstract available


    June 2018
  31. CECCONI M, Evans L, Levy M, Rhodes A, et al
    Sepsis and septic shock.
    Lancet. 2018 Jun 21. pii: S0140-6736(18)30696.
    PubMed     Text format     Abstract available


  32. SALAMA PJ, Embarek PKB, Bagaria J, Fall IS, et al
    Learning from listeria: safer food for all.
    Lancet. 2018;391:2305-2306.
    PubMed     Text format    


  33. THE LANCET
    Active case finding for communicable diseases in prisons.
    Lancet. 2018;391:2186.
    PubMed     Text format    



  34. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    Lancet. 2018;391:2236-2271.
    PubMed     Text format     Abstract available


    May 2018
  35. THE LANCET
    Balancing treatment with resistance in UTIs.
    Lancet. 2018;391:1966.
    PubMed     Text format    


  36. QADRI F, Azad AK, Flora MS, Khan AI, et al
    Emergency deployment of oral cholera vaccine for the Rohingya in Bangladesh.
    Lancet. 2018;391:1877-1879.
    PubMed     Text format    


  37. LESSLER J, Moore SM, Luquero FJ, McKay HS, et al
    Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales.
    Lancet. 2018;391:1908-1915.
    PubMed     Text format     Abstract available


  38. MINTZ E
    Taking aim at cholera.
    Lancet. 2018;391:1868-1870.
    PubMed     Text format    


  39. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed     Text format    


  40. GUENOT M
    Roger Glass: celebrating the Fogarty at 50.
    Lancet. 2018;391:1765.
    PubMed     Text format    


    April 2018
  41. CHU DK, Kim LH, Young PJ, Zamiri N, et al
    Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
    Lancet. 2018;391:1693-1705.
    PubMed     Text format     Abstract available


  42. COSTELLO A
    The Global Fund links with Lombard Odier bank.
    Lancet. 2018;391:1674-1675.
    PubMed     Text format    


  43. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    PubMed     Text format     Abstract available


  44. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed     Text format    


    March 2018
  45. PARK KB, Khan U, Seung K
    Open letter to The Global Fund about its decision to end DPRK grants.
    Lancet. 2018;391:1257.
    PubMed     Text format    


  46. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed     Text format    


  47. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    


  48. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed     Text format    


  49. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed     Text format    


  50. MCCALL C
    Rheumatic heart disease in the Pacific island nations.
    Lancet. 2018;391:926.
    PubMed     Text format    


    February 2018
  51. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    PubMed     Text format    


  52. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    PubMed     Text format    


  53. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    PubMed     Text format    


  54. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    PubMed     Text format    


  55. HONIGSBAUM M
    Superbugs and us.
    Lancet. 2018;391:420.
    PubMed     Text format    


    January 2018
  56. ZAROCOSTAS J
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    PubMed     Text format    


  57. THE LANCET
    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    PubMed     Text format    


  58. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed     Text format    


    December 2017
  59. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    PubMed     Text format    


  60. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    PubMed     Text format     Abstract available


    September 2017
  61. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


    July 2017
  62. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: